# Sevoflurane PharmacokInetics in ARDS

> **NCT04023305** · NA · TERMINATED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 37 (actual)

## Conditions studied

- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** Deep sedation by Sevoflurane on the Morphotype of ARDS in ICU patieNts

## Key facts

- **NCT ID:** NCT04023305
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-02-23
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** Recruitment difficulties
- **Last updated:** 2023-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04023305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04023305, "Sevoflurane PharmacokInetics in ARDS". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04023305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*